lidocaine has been researched along with mupirocin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Aksoy, A; Buyukkocak, U; Caglayan, O; Sedef Gocmen, J | 1 |
Najarian, DJ; Pappert, AS; Rao, BK | 1 |
Florek, CA; Kohn, J; Michniak, BB; Thakur, RA | 1 |
Li, X; Liu, P; Wang, C; Yang, S; Zhang, B | 1 |
Demirci, M; Kesici, S; Kesici, U | 1 |
6 other study(ies) available for lidocaine and mupirocin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vitro antibacterial effects of topical local anesthetics.
Topics: Administration, Cutaneous; Anesthetics, Local; Anti-Bacterial Agents; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Humans; In Vitro Techniques; Lidocaine; Microbial Sensitivity Tests; Mupirocin; Prilocaine; Pseudomonas aeruginosa; Reproducibility of Results; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pyogenes | 2008 |
A case of mucous membrane plasmacytosis successfully treated with cryotherapy.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Cryotherapy; Drug Resistance; Hemorrhage; Hepatitis C, Chronic; Humans; Hydrocortisone; Impetigo; Lidocaine; Lip Diseases; Male; Middle Aged; Mouth Mucosa; Mupirocin; Plasma Cells | 2008 |
Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing.
Topics: Anesthetics, Local; Anti-Bacterial Agents; Bacteria; Bandages; Calorimetry, Differential Scanning; Cell Proliferation; Cell Survival; Cells, Cultured; Drug Delivery Systems; Electrochemistry; Fibroblasts; Humans; Lidocaine; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Mupirocin; Nanotubes; Polymers | 2008 |
Electrospun PCL/mupirocin and chitosan/lidocaine hydrochloride multifunctional double layer nanofibrous scaffolds for wound dressing applications.
Topics: Anti-Bacterial Agents; Bacteria; Bandages; Cell Death; Chitosan; Drug Liberation; Fibroblasts; Humans; Lidocaine; Microbial Sensitivity Tests; Mupirocin; Nanofibers; Particle Size; Polyesters; Porosity; Spectroscopy, Fourier Transform Infrared; Temperature; Tissue Scaffolds; Water; Wounds and Injuries | 2018 |
Antimicrobial effects of local anaesthetics.
Topics: Anesthetics, Local; Anti-Bacterial Agents; Escherichia coli; Humans; Lidocaine; Mupirocin; Pseudomonas aeruginosa; Staphylococcus aureus | 2019 |